![](/img/cover-not-exists.png)
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Schwartzberg, Lee S., Wang, Grace, Somer, Bradley G., Blakely, L. Johnetta, Wheeler, Benton M., Walker, Mark S., Stepanski, Edward J., Houts, Arthur C.Volume:
14
Language:
english
Journal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2013.09.003
Date:
February, 2014
File:
PDF, 276 KB
english, 2014